SCOPUS 정보 검색 플랫폼

Volumn 26, Issue 1, 2001, Pages 20-24

KW-6002: Antiparkinsonian antidepressant adenosine A2A antagonist

(5) Rabasseda, X a Sorbera, L A a Martin, L a Leeson, P A a Castaner J a

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; ADENOSINE A2A RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BROMOCRIPTINE; CAFFEINE; HALOPERIDOL; ISTRADEFYLLINE; LEVODOPA; RESERPINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CHEMICAL ANALYSIS; CHEMICAL REACTION; DEPRESSION; DOPAMINE RELEASE; DOSE RESPONSE; DRUG INDUCED DISEASE; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PARKINSON DISEASE; RAT; REACTION ANALYSIS; RECEPTOR AFFINITY; SYNAPTIC TRANSMISSION;

EID: 0035109083 PISSN: 03778282 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (11)

References (39)

1
- 0000295727
- Reactions of 1,3-dimenthyl-5,6-diaminouracil
- (1954) J Am Chem Soc , vol.76 , pp. 2798-2800
- Blicke, F.F.¹ Godt H.C., Jr.²

2
- 4243459517
- JP 1997040652
- Preparation of uracil derivs
- Miwa, K.¹ Ito, K.² Kato, N.³ Kuge, Y.⁴ Kousai, M.⁵ Tomioka, S.⁶

3
- 0005792166
- EP 0590919, JP 1994211856, US 5484920
- Therapeutic agents for Parkinson's disease
- Suzuki, F.¹ Shimada, J.² Koike, N.³ Nakamura, J.⁴ Shiozaki, S.⁵ Ichikawa, S.⁶ Nonaka, H.⁷

4
- 0005791469
- EP 0628311, JP 1994502746, WO 9401114
- Antidepressant
- Suzuki, F.¹ Shimada, J.² Ishi, A.³ Nakamura, J.⁴ Ichikawa, S.⁵ Kitamura, S.⁶ Koike, N.⁷

5
- 17044440786
- 2A antagonists with potent anti-cataleptic activity
- (1997) Bioorg Med Chem Lett , vol.7 , pp. 2349-2352
- Shimada, J.¹ Koike, N.² Nonaka, H.³

6
- 4243526818
- Prous Science Drug R & D Backgrounders: Updated Sept 8
- (2000) Parkinson's disease (online publication)

7
- 0033639016
- 2A adenosine receptor atagonists - Future drugs for Parkinson's disease?
- (2000) Drugs Fut , vol.25 , pp. 1043-1052
- Müller, C.E.¹

8
- 0031756703
- 2A receptor antagonists in the treatment of movement disorders
- (1998) CNS Drugs , vol.10 , pp. 311-320
- Mally, J.¹ Stone, T.W.²

9
- 0005795413
- 2A receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons
- Abst 764.6
- (1997) Soc Neurosci Abst , vol.23 , Issue.PART 2
- Mori, A.¹ Shindou, T.² Ochi, M.³ Ichimura, M.⁴ Nonaka, H.⁵ Kase, H.⁶

10
- 0000411012
- 2a receptor antagonists
- Abst P452
- (1997) Mov Disord , vol.12 , Issue.SUPPL. 1
- Nonaka, H.¹ Saki, M.² Ichimura, M.³ Kase, H.⁴

11
- 0005834796
- 2a receptor antagonist, KW-6002
- Abst P464
- (1997) Mov Disord , vol.12 , Issue.SUPPL. 1
- Shimada, J.¹ Koike, N.² Shiozaki, S.³ Ichikawa, S.⁴ Kanda, T.⁵ Nonaka, H.⁶ Kase, H.⁷ Suzuki, F.⁸

12
- 0032778373
- 2A receptor in vivo
- (1999) J Label Compd Radiopharm , vol.42 , Issue.SUPPL. 1
- Gillies, J.¹ Luthra, S.K.² Brady, F.³ Karasawa, A.⁴ Shimada, J.⁵ Kase, H.⁶ Brooks, D.J.⁷

13
- 0003331110
- 2A adenosine receptor antagonists in relevant rodent models
- Abst 087
- (2000) Drug Dev Res , vol.50 , Issue.1
- Monopoli, A.¹ Impagnatiello, F.² Bastia, E.³ Fredduzzi, S.⁴ Ongini, E.⁵

14
- 0033219932
- 2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP
- (1999) Psychopharmacology , vol.147 , pp. 90-95
- Shiozaki, S.¹ Ichikawa, S.² Nakamura, J.³ Kitamura, S.⁴ Yamada, K.⁵ Kuwana, Y.⁶

15
- 0005790578
- 2AR) antagonist KW-6002 is antiparkinsonian in experimental models
- Abst P4.102
- (1998) Mov Disord , vol.13 , Issue.SUPPL. 2
- Kuwana, Y.¹ Shiozaki, S.² Kanda, T.³ Jenner, P.⁴

16
- 0034711582
- 2A receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemiparkinsonian rats
- (2000) Eur J Pharmacol , vol.408 , pp. 249-255
- Koga, K.¹ Kurokawa, M.² Ochi, M.³ Nakamura, J.⁴ Kuwana, Y.⁵

17
- 0034255509
- 2A receptor antagonist
- (2000) J Neurosci , vol.20 , pp. 5848-5852
- Aoyama, S.¹ Kase, H.² Borrelli, E.³

18
- 0031594271
- 2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys
- (1998) Ann Neurol , vol.43 , pp. 507-513
- Kanda, T.¹ Jackson, M.J.² Smith, L.A.³ Pearce, R.K.B.⁴ Nakamura, J.⁵ Kase, H.⁶ Kuwana, Y.⁷ Jenner, P.⁸

19
- 0002290747
- 2A receptor antagonist KW-6002 on parkinsonism induced by MPTP in common marmosets
- Abst P319
- (1997) Mov Disord , vol.12 , Issue.SUPPL. 1
- Nomoto, M.¹ Kaseda, S.² Iwata, S.³ Fukuda, T.⁴

20
- 0032563388
- 2A receptors modify motor function in MPTP-treated common marmosets
- (1998) NeuroReport , vol.9 , pp. 2857-2860
- Kanda, T.¹ Tashiro, T.² Kuwana, Y.³ Jenner, P.⁴

21
- 0034049544
- 2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
- (2000) Exp Neurol , vol.162 , pp. 321-327
- Kanda, T.¹ Jackson, M.J.² Smith, L.A.³ Pearce, R.K.B.⁴ Nakamura, J.⁵ Kase, H.⁶ Kuwana, Y.⁷ Jenner, P.⁸

22
- 0005792168
- 2A antagonists: New therapeutic approach against Parkinson's disease
- Abst L-8
- (2000) 20th Symp Med Chem
- Suzuki, F.¹

23
- 0005789147
- 2A antagonists are antiparkinsonian in MPTP treated primates
- (July 9-14, Kyoto), Abst G4.9
- (1995) 4th IBRO World Cong Neurosci
- Kanda, T.¹ Kuwana, Y.² Jenner, P.³ Nakamura, J.⁴ Kase, H.⁵ Hirata, T.⁶

24
- 0005866578
- 2A receptor antagonism as an alternative therapy for Parkinson's disease. A study in nonhuman primates
- H. Kase, P.J. Richardson and P. Jenner (Eds.), Academic Press, San Diego
- (2000) Adenosine Antagonists and Parkinson's Disease , pp. 229-244
- Tahar, A.H.¹ Grondin, R.² Gregoire, L.³ Bédard, P.J.⁴ Mori, A.⁵ Kase, H.⁶

25
- 0344052684
- 2A receptor antagonist in MPTP-treated monkeys
- (1999) Neurology , vol.52 , pp. 1673-1677
- Grondin, R.¹ Bédard, P.J.² Tahar, A.H.³ Grégoire, L.⁴ Mori, A.⁵ Kase, H.⁶

26
- 0005834470
- Pharmacokinetics of KW-6002, a treatment of Parkinson's
- Abst 11PD-64
- (2000) Xenobiotic Metab Dispos , vol.15 , Issue.SUPPL.
- Uchimura, T.¹ Fujita, K.² Yamazaki, A.³ Kobayashi, H.⁴

27
- 0005881525
- Distribution of KW-6002, a novel antiparkinsonian agent, in rat brain
- Abst 12PD-61
- (2000) Xenobiotic Metab Dispos , vol.15 , Issue.SUPPL.
- Fukayama, T.¹ Kobayashi, H.²

28
- 0005795716
- Kyowa Hakko Annual Report
- (2000)

29
- 0005902208
- KW-6002 Phase II clinical study in depression was started in the U S
- July 11
- (2000) Kyowa Hakko Press Release

30
- 0030075741
- 2a adenosine receptor antagonist
- (1996) J Pharmacol Exp Ther , vol.276 , pp. 398-404
- Zocchi, C.¹ Ongini, E.² Conti, A.³ Monopoli, A.⁴ Negretti, A.⁵ Baraldi, P.G.⁶ Dionisotti, S.⁷

31
- 0033371401
- 2B receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity
- (1999) Drug Dev Res , vol.48 , pp. 95-103
- De Zwart, M.¹ Vollinga, R.C.² Beukers, M.W.³ Sleegers, D.F.⁴ Kunzel, J.K.F.D.⁵ De Groote, M.⁶ Ijzerman, A.P.⁷

32
- 0025181328
- Imidazodiazepinediones: A new class of adenosine receptor antagonists
- (1990) J Med Chem , vol.33 , pp. 2818-2821
- Daly, J.W.¹ Hide, I.² Bridson, P.K.³

33
- 0022558934
- 3H]NECA in rat striatal membranes
- (1986) Mol Pharmacol , vol.29 , pp. 331-346
- Bruns, R.F.¹ Lu, G.H.² Pugsley, T.A.³

34
- 0031432945
- 1 receptors
- (1997) Drug Dev Res , vol.42 , pp. 86-97
- Thomsen, C.¹ Valsborg, J.S.² Foged, C.³ Knutsen, L.⁴

35
- 0004895639
- 2a adenosine receptor antagonist KW-6002 in MPTP treated cynomolgus monkeys
- Abst S.24.4
- (2000) Int J Neuropsychopharmacol , vol.3 , Issue.SUPPL. 1
- Bédard, P.J.¹ Grondin, R.² Tahar, A.H.³ Kase, H.⁴ Mori, A.⁵

36
- 0005790952
- Drug discovery and purines
- Abst R01-R01
- (2000) Drug Dev Res , vol.50 , Issue.1
- Williams, M.¹

37
- 0005831532
- 2a adenosine receptor antagonist KW-6002 has antiparkinsonian activity in MPTP treated cynomolgus monkeys
- Abst P4.157
- (1998) Mov Disord , vol.13 , Issue.SUPPL. 2
- Bédard, P.J.¹ Grondin, R.² Tahar, A.H.³ Kase, H.⁴ Mori, A.⁵

38
- 0005875554
- 2a receptor antagonist KW-6002 in Parkinson's disease
- Abst 783.13
- (1997) Soc Neurosci Abst , vol.23 , Issue.PART 2
- Grondin, R.¹ Tahar, A.H.² Grégoire, L.³ Kase, H.⁴ Mori, A.⁵ Bédard, P.J.⁶

39
- 0005791302
- 2A adenosine receptor antagonists are antiparkinsonian in animal models
- Abst 119.14
- (1997) Soc Neurosci Abst , vol.23 , Issue.PART 1
- Kuwana, Y.¹ Shiozaki, S.² Kanda, T.³ Kurokawa, M.⁴ Koga, K.⁵ Ochi, M.⁶ Ikeda, K.⁷ Jenner, P.⁸

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.